These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 8941027
1. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans. Hartigan-Go K, Bateman DN, Nyberg G, Mårtensson E, Thomas SH. Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027 [Abstract] [Full Text] [Related]
2. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. Salih IS, Thanacoody RH, McKay GA, Thomas SH. Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment. Daniel WA, Syrek M, Mach A, Wójcikowski J, Boksa J. Pol J Pharmacol; 1997 Nov; 49(6):439-52. PubMed ID: 9566048 [Abstract] [Full Text] [Related]
4. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A. Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264 [Abstract] [Full Text] [Related]
8. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women. Peck RW, Seaber EJ, Dixon RM, Layton GR, Weatherley BC, Jackson SH, Rolan PE, Posner J. Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478 [Abstract] [Full Text] [Related]
10. Human pharmacology of the methamphetamine stereoisomers. Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT. Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058 [Abstract] [Full Text] [Related]
11. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study. Zhang L, Chappell J, Gonzales CR, Small D, Knadler MP, Callaghan JT, Francis JL, Desaiah D, Leibowitz M, Ereshefsky L, Hoelscher D, Leese PT, Derby M. J Cardiovasc Pharmacol; 2007 Mar; 49(3):146-53. PubMed ID: 17414226 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers. Lal R, Sukbuntherng J, Luo W, Chen D, Vu A, Tovera J, Cundy KC. Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136 [Abstract] [Full Text] [Related]
16. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers. Wang Z, Grasela DM, Krishna G. Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724 [Abstract] [Full Text] [Related]
17. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals. Couderc JP, Zhou M, Sarapa N, Zareba W. J Electrocardiol; 2008 Jun; 41(6):595-602. PubMed ID: 18801493 [Abstract] [Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J. Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [Abstract] [Full Text] [Related]